Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects

M Ingelman-Sundberg, SC Sim, A Gomez… - Pharmacology & …, 2007 - Elsevier
The polymorphic nature of the cytochrome P450 (CYP) genes affects individual drug
response and adverse reactions to a great extent. This variation includes copy number …

Polymorphism of human cytochrome P450 enzymes and its clinical impact

SF Zhou, JP Liu, B Chowbay - Drug metabolism reviews, 2009 - Taylor & Francis
Pharmacogenetics is the study of how interindividual variations in the DNA sequence of
specific genes affect drug response. This article highlights current pharmacogenetic …

Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance

UM Zanger, K Klein - Frontiers in genetics, 2013 - frontiersin.org
Cytochrome P450 2B6 (CYP2B6) belongs to the minor drug metabolizing P450s in human
liver. Expression is highly variable both between individuals and within individuals, owing to …

Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study

DW Haas, HJ Ribaudo, RB Kim, C Tierney… - Aids, 2004 - journals.lww.com
Objectives: Efavirenz is an effective antiretroviral agent, but central nervous system side
effects occur commonly, and population (racial) differences in pharmacokinetics and …

Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms

M Ingelman-Sundberg - Naunyn-Schmiedeberg's archives of …, 2004 - Springer
The cytochrome P450s are responsible for about 75% of phase I dependent drug
metabolism and for the metabolism of a huge amount of dietary constituents and …

Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients

M Rotger, S Colombo, H Furrer, G Bleiber… - Pharmacogenetics …, 2005 - journals.lww.com
Background Efavirenz (EFV) and nevirapine (NVP) are metabolized by cytochrome P450
2B6 (CYP2B6). Allele 516 G> T (Gln172His) is associated with diminished activity of this …

Pharmacokinetic interactions of curcuminoids with conventional drugs: A review

R Bahramsoltani, R Rahimi, MH Farzaei - Journal of ethnopharmacology, 2017 - Elsevier
Ethnopharmacological relevance Herb–drug interactions are of great concern in health
practices. Curcumin is a natural polyphenol extracted from turmeric, a spice widely used all …

Genistein: Its role in metabolic diseases and cancer

V Mukund, D Mukund, V Sharma, M Mannarapu… - Critical Reviews in …, 2017 - Elsevier
Genistein is an isoflavone present in soy and is known to have multiple molecular effects,
such as the inhibition of inflammation, promotion of apoptosis, and modulation of steroidal …

Cunninghamella–a microbial model for drug metabolism studies–a review

S Asha, M Vidyavathi - Biotechnology advances, 2009 - Elsevier
Drug metabolism studies constitute an important and necessary step in the evaluation of
drug efficacy and safety. In vivo drug metabolism studies suffer from many disadvantages …

Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance

UM Zanger, K Klein, T Saussele, J Blievernicht… - 2007 - Taylor & Francis
Polymorphisms in drug-metabolizing enzymes and drug transporters contribute to wide and
inheritable variability in drug pharmacokinetics, response and toxicity. One of the less well …